Clinical Trial Update: A Safety and Efficacy Study of Daikenchuto (TU-100) to Relieve Abdominal Bloating in Female Subjects With Irritable Bowel Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 study evaluated the safety and efficacy of Daikenchuto (TU-100) for relieving abdominal bloating in women with irritable bowel syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Daikenchuto (TU-100) (Daikenchuto)

Snippet

Sponsor: Tsumura USA | Conditions: Irritable Bowel Syndrome in Females | Phase 2 | Status: COMPLETED